Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.042530 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Brett W Sperry und 14 weiteren Autor:innen. Beteiligte Einrichtung: Saint Luke's Mid America Heart Institute Kansas City MO USA. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Diagnostic rates of transthyretin cardiac amyloidosis have increased due to growing awareness, noninvasive diagnoses, and treatments that improve morbidity and mortality. We sought to investigate real‐world trends in baseline characteristics and survival in the United States.
Methods
Patient‐level data at 5 cardiac amyloid referral centers were used, and mortality (defined as death or surgical heart failure therapies) was compared by eras (pre‐2010, 2010–2013, 2014–2017, and 2018–2021) and National Amyloidosis Center (NAC) stage.
Results
Among 1165 subjects, diagnosis of transthyretin cardiac amyloidosis in a more recent era was associated with older age, white race, wild‐type disease, and tafamidis treatment ( P 1 portended an increased risk of death (stage 2: HR, 2.00; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Saint Luke's Mid America Heart Institute Kansas City MO USA.
- Oregon Health Sciences University Portland OR USA.
- University of Pittsburgh Medical Center Pittsburgh PA USA.
- Columbia University Irving Medical Center New York NY USA.
- Cleveland Clinic Foundation Cleveland OH USA.
ORCID-Profile: Brett W Sperry, Ahmad Masri, Prem Soman, Priyanka Bhattacharya, Brent Medoff, Pranav Chandrashekar, Lauren Ives, Alfonsina Mirabal Santos, Sergio L Teruya, Yanjun Wu, Xiaofeng Wang, Mathew S Maurer
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Sperry, B. W., Masri, A., Soman, P., Ejaz, A. U., Bhattacharya, P., Medoff, B., Chandrashekar, P., Ives, L., Mirabal Santos, A., Teruya, S. L., Wu, Y., Zhao, Y., Wang, X., Maurer, M. S., & Hanna, M. (2025). Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042530
Vancouver
Sperry BW, Masri A, Soman P, Ejaz AU, Bhattacharya P, Medoff B, et al. Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042530
BibTeX
@article{Sperry2025,
author = {Sperry, Brett W and Masri, Ahmad and Soman, Prem and Ejaz, Ain U and Bhattacharya, Priyanka and Medoff, Brent and Chandrashekar, Pranav and Ives, Lauren and Mirabal Santos, Alfonsina and Teruya, Sergio L and Wu, Yanjun and Zhao, Yuanzi and Wang, Xiaofeng and Maurer, Mathew S and Hanna, Mazen},
title = {Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.042530}
}
EUVIMED